Mergers & Acquisitions
-
2019.03.01
So, When is the GE Healthcare IPO Happening?
General Electric announced earlier this week that it would sell its pharmaceutical unit to Danaher for about $21 billion.
Read More -
2019.01.02
Alcon’s Acquisition Is a Real Tear-Jerker
Alcon acquired Tear Film Innovations, a company that makes a device to treat a leading cause of dry eye.
Read More -
2018.12.05
Auris Scores Big with $200M Raise for Robotics Platform
The Redwood City, CA-based company’s financing raise is the perfect example of the strength and support the robotics market now commands in healthcare.
Read More -
2018.11.27
Boston Sci Puts up $4B for BTG
The Marlborough, MA-based company hasn’t been shy about building up its portfolio through M&A, the only question now is can it slip in another deal before the end of the year.
Read More -
2018.07.24
Boston Sci Just Won’t Stop Buying Companies
The Marlborough, MA-based company is set to swoop in and pick up Claret Medical, an embolic protection specialist, in a deal worth $270 million.
Read More -
2018.07.18
Potrero Smartens up Its Catheter to Predict Diseases
The San Francisco, CA-based company has raised $26.6 million in a series C round to help further commercialize its Accuryn Monitoring System.
Read More -
2018.07.10
BASF acquires two manufacturers of 3D-printing materials
BASF New Business GmbH (BNB; Ludwigshafen, Germany) has acquired German and French companies involved with the manufacture
Read More -
2018.07.09
Boston Scientific to Acquire Cryterion Medical
Company to expand atrial fibrillation ablation therapy offerings with innovative cryoballoon platform.
Read More -
2018.07.04
Dare to ‘Dreem’: J&J Invests in Sleep-Focused Medtech Startup
Dreem, a neurotechnology startup developing sleep-related devices, raised $35 million in a round led by Johnson & Johnson’s investment arm.
Read More -
Dare to ‘Dreem’: J&J Invests in Sleep-Focused Medtech Startup
Dreem, a neurotechnology startup developing sleep-related devices, raised $35 million in a round led by Johnson & Johnson’s investment arm.
Read More